 |
|
|
| |
Hepatitis B Reactivation/Infection in People With HIV on Tenofovir-Sparing Antiretroviral Therapy
|
| |
| |
CROI 2026 Feb 22-25 Denver
Brief Report: Hepatitis B Infection or Reactivation After Switch to 2-Drug Antiretroviral Therapy: A Case Series, Literature Review, and Management Discussion, Four individuals with HBV infection or reactivation after ART switch were identified. Two-drug ART switch may pose risk of HBV infection or reactivation.
CROI2025: HBV Reactivation Post-switch to HBV-inactive ART: A Scoping Review- 1.6% reactivation
Grace Haser, Nadra Lisha, H. Nina Kim, Greer Burkholder, Edward Cachay, Heidi M. Crane,
Oluwaseun Falade-Nwulia, Julia Fleming, Mari Kitahata, April Pettit, Sarah Rutstein, George Yendewa, Katerina Christopoulos, Anne F. Luetkemeyer, for the Centers for AIDS Research Network of Integrated Clinical Systems (CNICS) Cohort
|
| |
|
|
|
|
|
